intraductal papillary mucnous neoplasm
Conditions
Interventions
None listed
Sponsors
Division of Gastroenterology, Department of Internal Medicine,Kobe University Graduate School of Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 69 consecutive patients with IPMNs in whom EUS was performed before surgical resection at Kobe University Hospital from April 2010 to October 2014
Exclusion criteria
Exclusion criteria: Patients with concomitant pancreatic carcinoma (defined by the presence of two discrete tumors)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Association of EUS-CP findings(chronic pancreatitis like change detected by EUS) with invasive IPMC | — |
Secondary
| Measure | Time frame |
|---|---|
| 2. Association of EUS-CP findings with pathological changes of the pancreatic parenchyma 3. Association of pathological changes in the pancreatic parenchyma with malignant IPMN | — |
Countries
Japan
Contacts
Public ContactMamoru Takaenaka
Kobe University Graduate School of Medicine Division of Gastroenterology, Department of Internal Medicine
Outcome results
None listed